NAGE

Niagen Bioscience

59 hedge funds and large institutions have $18.1M invested in Niagen Bioscience in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

6% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 17

5% less capital invested

Capital invested by funds: $19.1M → $18.1M (-$974K)

Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$146K
Puts
$41K
Net Calls
Net Calls Change

Top Sellers

1 -$300K
2 -$230K
3 -$220K
4
Barclays
Barclays
United Kingdom
-$168K
5
BlackRock
BlackRock
New York
-$127K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$42.2K
27
$41K
28
$37.7K
29
$34.9K
30
$33.7K
31
$32.1K
32
$32.1K
33
$30.6K
34
$29.3K
35
$28.9K
36
$27.5K
37
$27K
38
$27K
39
$25.2K
40
$23.5K
41
$22.9K
42
$18.4K
43
$18.1K
44
$16.3K
45
$15.3K
46
$14K
47
$9K
48
$7.65K
49
$5.36K
50
$4.59K